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Apoptosis is a common antiviral defensive mechanism that potentially limits viral reproduction and spread.
Many viruses possess apoptosis-suppressing tools. Here, we show that the productive infection of HeLa cells
with encephalomyocarditis virus (a cardiovirus) was not accompanied by full-fledged apoptosis (although the
activation of caspases was detected late in infection) but rather elicited a strong antiapoptotic state, as
evidenced by the resistance of infected cells to viral and nonviral apoptosis inducers. The development of the
antiapoptotic state appeared to depend on a function(s) of the viral leader (L) protein, since its mutational
inactivation resulted in the efflux of cytochrome c from mitochondria, the early activation of caspases, and the
appearance of morphological and biochemical signs of apoptosis in a significant proportion of infected cells.
Infection with both wild-type and L-deficient viruses induced the fragmentation of mitochondria, which in the
former case was not accompanied with cytochrome c efflux. Although the exact nature of the antiapoptotic
function(s) of cardioviruses remains obscure, our results suggested that it includes previously undescribed
mechanisms operating upstream and possibly downstream of the mitochondrial level, and that L is involved
in the control of these mechanisms. We propose that cardiovirus L belongs to a class of viral proteins, dubbed
here security proteins, whose roles consist solely, or largely, in counteracting host antidefenses. Unrelated L
proteins of other picornaviruses as well as their highly variable 2A proteins also may be security proteins.
These proteins appear to be independent acquisitions in the evolution of picornaviruses, implying multiple
cases of functional (though not structural) convergence.
Cells that are infected with a virus recognize the invader’s
presence by their innate immunity machinery and switch on a
variety of defensive mechanisms. The infecting virus, on the
other hand, may possess tools capable of interfering with host
antiviral responses. The outcome of the infection, both in
terms of the efficiency of virus growth and the extent of host
pathology, depends on the trade-off between these defensive
and counterdefensive measures.
Cellular innate immunity involves multiple pathways, and
one powerful defense is apoptosis, or the programmed self-
sacrifice of the infected cell, potentially limiting viral repro-
duction and spread (10). However, many viruses are able to
suppress this defensive mechanism (14, 37). Remarkably, vi-
rus-elicited pathology may be specific for a given type of cells
and a given virus. Unraveling the interplay between pathways
leading to the death or survival of the infected cells is an
important task that may provide clues to understanding viral
pathogenesis and, possibly, may indicate new directions for
searching for antiviral drugs.
Picornaviruses are a family of small nonenveloped animal
viruses that includes important human and animal pathogens
such as polioviruses, rhinoviruses, hepatitis A virus, foot-and-
mouth disease viruses, and many others (89). Their genome is
represented by a single-stranded 7.2- to 8-kb RNA molecule of
positive polarity encoding about a dozen mature proteins (gen-
erated by the limited proteolysis of a single polyprotein pre-
cursor), nearly all of which are directly involved in the repli-
cation of the viral RNA and formation of virions (1).
The first picornavirus demonstrated to interact with the host
cell apoptotic machinery by both triggering and suppressing
the apoptotic response was poliovirus (95). Since then, a
wealth of data has been accumulated that shows that the acti-
vation of apoptotic pathways is a widespread, though not uni-
versal, response to picornavirus infection. Thus, apoptosis-in-
ducing capacity was reported for coxsackieviruses B3, B4, and
B5 (22, 54, 82), enteroviruses 70 and 71 (25, 27, 60, 88), human
rhinoviruses 1B, 9, 14, and 16 (32, 92, 100), foot-and-mouth
disease virus (53, 76), avian encephalomyelitis virus (62, 63),
and hepatitis A virus (16, 43) and was the subject of several
recent reviews (15, 102). The antiapoptotic activity of picorna-
viruses was studied predominantly by using poliovirus (3, 8, 13,
72) and coxsackievirus B3 (21, 36, 85).
The present study is focused on the interaction of cardiovi-
ruses, which are representatives of a genus in the picornavirus
family, with the apoptotic machinery of infected cells. Our
interest in this topic stemmed from the fact that these viruses,
e.g., encephalomyocarditis virus (EMCV) and its strain men-
govirus (MV), as well as the less-related Theiler’s murine en-
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cephalomyelitis virus (TMEV), while sharing major features of
genome organization and reproductive strategy with other
family members, encode a unique protein that is not found in
other picornaviruses. Indeed, the leader (L) protein, a deriva-
tive of the N-terminal portion of the viral polyprotein (55),
appears to be a major player in controlling the virus-host in-
teraction. On the one hand, it is devoid of any known enzy-
matic activity, and L-lacking mutants are viable, at least in
certain cultured cells (19, 57, 106). On the other hand, the L
protein appears to inhibit host translation (35, 106), suppresses
interferon production (46, 83, 98), and impairs nucleocytoplas-
mic traffic (11, 30, 61, 80, 81). It has been hypothesized that
cardiovirus L protein also is involved in the interaction with
defensive apoptotic machinery.
Previous studies have demonstrated that TMEV infection
may induce apoptosis, especially in partially restrictive cells
(50, 51). EMCV also exerted a similar effect in certain cell lines
(87, 103). The reason(s) underlying variability in the apoptosis-
inducing effects of cardioviruses remains unexplained. Here,
we demonstrate that the productive cardiovirus infection of
susceptible HeLa cells resulted in their cytopathic death, which
was not accompanied by clear signs of apoptosis. On the con-
trary, the infected cells acquired an antiapoptotic state, as
evidenced by their failure to develop an apoptotic response to
viral and nonviral apoptosis inducers. However, the antiapop-
totic state failed to develop in cells infected with a mutant virus
with inactivated L, and this mutant instead elicited caspase-
dependent apoptosis preceded by cytochrome c efflux. These
data suggest that the wild-type (wt) L protein is involved,
directly or otherwise, in the control of viral antiapoptotic func-
tion(s).
MATERIALS AND METHODS
Cells and viruses. HeLa-B cells (95), human rhabdomyosarcoma RD cells, and
baby hamster kidney BHK-21 cells were grown in Dulbecco’s modified Eagle
medium with 10% fetal bovine serum. wt MV was derived from the plasmid
pM16.1 (34). An MV mutant encoding an L protein with a destroyed Zn finger,
C19A/C22A, was described previously (46). In control experiments, poliovirus
type 1 strain Mahoney was used.
Infection and single-cycle growth experiments. Cells were detached by EDTA
treatment, plated onto 35-mm petri dishes (Corning-Costar), and cultivated
overnight at 37°C under 5% CO2 in Eagle medium with 10% fetal bovine serum.
At the end of cultivation, the plates contained 7  105 to 9  105 cells. The
growth medium was discarded, and the virus was added in a volume of 1 ml to
provide the input multiplicity of infection (MOI) indicated. After a 30-min
incubation at room temperature, the cells were washed with 2.5 ml Eagle me-
dium, and 1 ml of serum-free Eagle medium was added. After incubation at 37°C
for the indicated time intervals, the cells were detached by EDTA treatment,
combined with the supernatant medium, subjected to three cycles of freezing-
thawing, and frozen at 80°C until viral plaque titration.
Plaque titration. For EMCV titration, RD cell monolayers grown on 35-mm
petri dishes for 3 days were used. The growth medium was discarded, and sample
dilutions were introduced in a volume of 0.1 ml. After virus adsorption for 30 min
at room temperature, the cells were overlaid with agarose (Amresco; final con-
centration of 0.4%), fetal bovine serum (2%), and neutral red (0.002%) in
Earle’s solution supplemented with 3% sodium bicarbonate and 1 mg/ml kana-
mycin. Plaque counts were made after a 24-h incubation at 37°C in 5% CO2. For
the plaque assay of MV and its mutant, 1-day cultures of BHK-21 cells were used.
The overlay in this case contained 0.9% agarose and no neutral red. After 2 or
3 days of incubation at 37°C in 5% CO2, the cultures were fixed with 10%
trichloroacetic acid, the overlay was removed, and the cells were stained with
0.15% crystal violet. BHK-21 cells, rather than RD cells, were used for the
titration of MV and its mutant, because the former cells are relatively more
permissive for the growth of L-deficient MV mutants (106). It should be noted,
however, that the titration of MVs on BHK-21 cells produced markedly fewer
plaques than on RD cells.
Real-time PCR. Total RNA was isolated from cell monolayers by TRI reagent
(Sigma) according to the manufacturer’s protocol, and its concentration was
determined spectrophotometrically. Two micrograms of RNA was reverse tran-
scribed with the avian myeloblastosis virus reverse transcriptase (Promega)
primed with oligonucleotide MG5 (GAATTCCTCTGCCAATAACC; corre-
sponding to nucleotides [nt] 6997 to 7016). The real-time reverse transcription-
PCR assays were performed on a Chromo4 four-color real-time PCR system
(Bio-Rad Laboratories) by using a commercially available real-time PCR kit
(Syntol, Russia) according to the supplier’s protocol with oligonucleotide prim-
ers MGVL1 (CGCTAGGAATGCGTAGAACA; nt 6601 to 6620) and MGVR1
(AGCTCGTCCTTGAGGAATGT; nt 6717 to 6736). Oligonucleotide MGVP1
(6-carboxyfluorescein-TGGGAAACCGCCACTCTTATCCC-black hole quenc
her 1; nt 6633 to 6655) was used as the probe. The standard curve was generated
by using serial dilutions (corresponding to 102 to 107 molecules) of a sucrose
gradient-purified (40) full-length RNA transcript of wt MV obtained from plas-
mid pM16.1. The thermal cycling conditions were as follows: 5 min at 95°C for
hot activation, followed by 45 cycles of 15 s at 95°C and 30 s at 61°C.
Apoptosis induction. Protein synthesis inhibitor cycloheximide (CHI; 100 g/
ml) or the transcription inhibitor actinomycin D (ActD; 3 g/ml) was used as a
nonviral inducer of apoptosis. To activate the apoptotic program by poliovirus
infection, the viral reproduction was interrupted at 1.5 h postinfection (p.i.) by
the addition of guanidine-HCl (100 g/ml) to the infected cells at either the
onset of infection or 1.5 h p.i. A broad-spectrum caspase inhibitor, Q-VD-OPh
(23), hereinafter referred to as QVD, was used to suppress apoptosis.
TUNEL assay. Infected and mock-infected cells were grown on coverslips for
the time intervals indicated, stained with Hoechst-33342, and fixed at room
temperature with Safe Fix for 30 min. The cells were treated with 96 and 70%
ethanol and stored at 20°C. The assay was performed by using the apoptosis
detection system fluorescein kit (Promega) according to the manufacturer’s
instructions. The filter cube I3 was used for the registration of TUNEL (terminal
deoxyribonucleotide transferase-mediated dUTP nick end labeling)-positive
cells.
DNA fragmentation electrophoretic assay. DNA fragmentation was assayed
essentially as described previously (95). Briefly, the cells were detached from the
plastic by EDTA treatment, suspended in a buffer containing 20 mM EDTA and
10 mM Tris-HCl, pH 7.4, and lysed with 0.5% Triton X-100 for 20 min in an ice
bath. The suspension was subjected to centrifugation in an Eppendorf minicen-
tifuge (12,000 rpm, 15 min, 4°C), and the nucleus-free supernatant was treated
with phenol-sodium dodecyl sulfate (SDS). The nucleic acids were precipitated
with ethanol, dissolved in 10 l of H2O, and treated with RNase A (10 g/ml,
37°C, 30 min). Samples were subjected to electrophoresis on 1.5% agarose gels.
Caspase activation assay. The caspase activity in cellular extracts was deter-
mined by measuring the cleavage of peptide Ac-DEVD-pNA, a synthetic analog
of the natural substrates of caspase-3 and -7. The determination of this DEV-
Dase activity was performed essentially as described previously (3). The cells
were lysed with cell lysis buffer from the Clontech CPP-32 colorimetric detection
kit. The enzymatic activity was determined in 100-l reaction mixtures containing
45 l of cell lysate, 100 M Ac-DEVD-pNA (Calbiochem), 50 l of 2 reaction
buffer [100 mM piperazine-N,N-bis(2-ethanesulfonic acid), pH 7.0, 0.2 mM
EDTA, 20% glycerol, 2 mM dithiothreitol], and where indicated, 10 M zVAD-
(OMe)–fmk. The optical density was measured at 405 nm. For the identification
of activated caspases, extracts of virus-infected and mock-infected cells were
prepared by sonication and heating for 10 min at 95°C in lysis buffer (2% SDS,
50 mM 2-mercaptoethanol, 50 mM Tris-HCl [pH 6.8]), and the conversion of
procaspases into caspases was investigated by Western blotting by using anti-
caspase-3 (585), anti-caspase-8 (3-1-3), and anti-caspase-9 (824) antibodies (all
from Santa Cruz). Anti-actin antibodies were from Sigma.
Mitochondria fragmentation and cytochrome c efflux assays. HeLa-B cells or
HeLa-B cells expressing the enhanced yellow fluorescent protein fused with the
mitochondria-targeting sequence from subunit VIII of human cytochrome c
oxidase (EYFP-mito) were used. The latter was obtained by transformation with
pEYFP-mito vector (Clontech). One-day-old subconfluent monolayers on cov-
erslips were infected and/or exposed to inhibitors for the indicated times. The
immunostaining was performed as described previously (11). Briefly, infected
and mock-infected cells were fixed for 20 min with 3.7% paraformaldehyde in
phosphate-buffered saline (PBS), washed, and permeabilized with 0.2% Triton
X-100 in PBS for 10 min. Cells were washed three times with PBS for 5 min each
and blocked with 1% bovine serum albumin (BSA) for 1 h at 37°C. The incu-
bations with primary (anti-cytochrome c; Pharmingen) and secondary (anti-
mouse IgG-Alexa 546 conjugate; Invitrogen) antibodies were performed at 37°C
in buffer for immunofluorescence (0.1% BSA, 0.05% Tween-20 in PBS). The
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cells then were washed three times for 5 min with the same buffer. The second
wash contained Hoechst-33342 dye. The coverslips were mounted in Mowiol and
inspected with Leica DMLS or Zeiss Axiovert 200M microscopes.
Image processing. The color images obtained by microscopy were transformed
into the grayscale mode by using Adobe Photoshop 7.0. Developed films (in the
Western blot assays) were scanned and processed with the same program. When
appropriate, the brightness and contrast of the whole row of grayscale pictures in
a given panel were equally optimized (to make visible details presented in the
color images) by using the Brightness/Contrast tool of Adobe Photoshop 7.0. In
the case of Fig. 2, three-dimensional image stacks underwent equal deconvolu-
tion for each fluorochrome channel using Axiovision release 3.1 software (Carl
Zeiss).
RESULTS
Antiapoptotic state and cytopathic (necrotic) death of HeLa
cells productively infected with EMCV. HeLa cells are permis-
sive for EMCV, and the viral yield may approach 104 PFU/cell
by 6 to 8 h p.i. (Fig. 1A). By this time, the overwhelming
majority of infected cells died, exhibiting typical signs of cyto-
pathic effect, with the rounding up and complete disorganiza-
tion of the cytoplasmic structure as seen by phase-contrast
microscopy, as well as moderate chromatin condensation and
nuclear deformation and shrinking as seen upon Hoechst
staining (Fig. 1B). No ostensible signs of apoptosis could be
detected in the infected cells. Indeed, nuclear fragmentation
was not observed and chromatin condensation was not as in-
tense as that seen in typical apoptosis (e.g., induced by restric-
tive poliovirus infection [Fig. 1B] or the nonviral apoptotic
inducer ActD [see Fig. 3A]). When assayed for DNA degra-
dation by TUNEL assay, many infected cells produced only a
very faint signal (Fig. 1B). Also, only a slight degradation of
cellular DNA to high-molecular-mass species could be ob-
served at late steps of EMCV infection by electrophoretic
analysis (Fig. 1C). Neither cytopathic effect nor viral yield was
appreciably affected by a pan-caspase inhibitor, QVD (Fig. 1).
EMCV infection did not cause any marked cytochrome c re-
FIG. 1. EMCV reproduction in HeLa cells. (A) One-step growth curve. Cells were infected at an input MOI of 500 PFU/cell, and the harvest
was plaque assayed in RD cells. Results from a separate experiment performed in the absence (solid symbols) or presence (open symbols) of 20
M QVD are presented in the inset. (B) Mock-infected cells, EMCV-infected cells, and cells abortively infected with poliovirus (i.e., with 100
g/ml of guanidine-HCl added at 1.5 h p.i. [poliogua]), all in the absence or presence of 20 M QVD, were fixed at 7 h p.i. and stained for the
TUNEL assay and with Hoechst-33342. (C) Electrophoretic investigation of DNA from samples similar to those shown in panel B.
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lease from mitochondria, another hallmark of apoptosis, but
unexpectedly, the extensive fragmentation of mitochondria
could be observed (Fig. 2). Indeed, a network of thread-like
mitochondria was transformed into a set of punctated struc-
tures in the infected cell. Of note, mitochondrial fission is
known to be a factor involved in the control of apoptotic
machinery (24, 77, 104).
Remarkably, EMCV induced an antiapoptotic state, as evi-
denced by the resistance of the infected cells to a nonviral
apoptotic inducer. The treatment of uninfected cells with 3
g/ml of ActD for 5 h resulted in the development of apoptosis
in a significant proportion of cells, judging by morphological
(cytoplasmic blebbing, strong chromatin condensation, and nu-
clear fragmentation) and biochemical (positive TUNEL signal
and DNA fragmentation to oligonucleosome-sized fragments)
criteria. All of these alterations could be prevented by QVD,
confirming that ActD treatment led to a bona fide caspase-
dependent apoptosis. The ActD-induced apoptosis was
strongly, if not completely, suppressed in EMCV-infected cells
(Fig. 3A to C). EMCV infection also prevented cytochrome c
efflux from mitochondria caused by ActD treatment (Fig. 3D).
Since EMCV prevented mitochondria damage-mediated cyto-
chrome c efflux, we conclude that the viral antiapoptotic mech-
anism operated, at least in part, at the mitochondrial level or
upstream of mitochondria. The yield of infectious cardiovi-
ruses is known to be essentially unaffected by ActD, and in the
experiment shown in Fig. 3, 1.2  104 PFU/cell were pro-
duced by 5 h p.i. in the presence and absence of the drug. ActD
did not prevent cell destruction caused by EMCV (Fig. 3).
As shown previously (2, 95) (Fig. 1), restrictive poliovirus
infection induces apoptosis as a result of the activation of a
mitochondrion-dependent and caspase-dependent pathway
(13). This apoptosis also was suppressed by coinfection with
MV (Fig. 4).
All of these data strongly suggested that EMCV infection
switched on an antiapoptotic program in the infected cells.
Mutant cardiovirus with impaired L protein induced apop-
tosis. To ascertain the possible involvement of cardiovirus L
protein in the control of apoptotic machinery, an L-deficient
variant of MV with two mutations, C19A/C22A, destroying the
Zn finger motif of the protein (46) was investigated. Previous
studies showed that the destruction of this motif resulted in the
functional inactivation of L (46, 61).
At 5 h p.i., the C19A/C22A mutant produced usually, but not
always, severalfold fewer infectious virus particles than did its
wt counterpart, and this difference was somewhat increased by
7 h p.i. (Fig. 5A). However, in some experiments, the mutant
and wt MV exhibited more similar growth curves (not shown).
The quantification of viral RNA molecules by real-time PCR
(Fig. 5B) demonstrated a good parallelism between RNA rep-
lication and the generation of infectious progeny, with very
close ratios of the number of RNA molecules to PFU for both
the wt and C19A/C22A mutant (not shown). As could be
expected, this ratio somewhat decreased with time, likely re-
flecting the maturation of virions. Infection with the mutant
ended up with complete cell destruction (Fig. 6A).
In distinction from the wt MV, the L-deficient mutant elic-
ited a marked apoptosis in HeLa cells, as judged by cytoplas-
mic blebbing, chromatin condensation, nuclear fragmentation,
TUNEL assay (Fig. 6A, B), and DNA laddering (Fig. 6C)
criteria. None of these signs of apoptosis could be seen in
the mutant-infected cells incubated in the presence of QVD
(Fig. 6).
One may argue that the activation of the apoptotic program
is due to a somewhat less efficient reproduction of the L-
deficient mutant. Indeed, the interruption of ongoing poliovi-
rus reproduction at an early step by the inhibition of transla-
tion by a low dose (10 g/ml) of CHI (by itself not inducing
apoptosis in a significant proportion of cells) resulted in the
suppression of the viral antiapoptotic program and the devel-
opment of apoptosis (3). We investigated whether a similar
treatment also would activate the apoptotic program in cardio-
virus-infected cells. CHI addition at 1.5 h p.i. diminished the
yield of infectious virus by 103-fold. However, such a treat-
ment did not lead to an increase in the proportion of TUNEL-
positive cells in the EMCV-infected population, although the
fraction of such cells in the uninfected population slightly in-
creased (Fig. 7). As expected (3), CHI addition to poliovirus-
infected cells, which were used as a control, resulted in the
development of an appreciable apoptotic response. We con-
cluded that a significant suppression of ongoing cardiovirus
reproduction did not result, by itself, in the development of
apoptosis.
Thus, in distinction from wt cardioviruses inducing an anti-
apoptotic state, L-deficient MV activated the apoptotic pro-
gram, suggesting that L protein was involved, directly or oth-
erwise, in the control of the apoptotic machinery of the
infected cells.
The apoptotic pathway activated by L-deficient cardiovirus
mutants. The prevention by QVD of apoptosis triggered by the
L mutant (Fig. 6) suggested the involvement of a caspase(s).
This conclusion was supported by measuring the DEVDase
FIG. 2. Fragmentation of mitochondria without cytochrome c ef-
flux upon productive EMCV infection. Mock-infected and EMCV-
infected HeLa cells were incubated for 5 h, immunostained for cyto-
chrome c, and stained for DNA with Hoechst-33342. Alterations in the
nuclear shape and structure, typical of cytopathic effect, revealed by
Hoechst staining indicated that the cells in the right panel were un-
dergoing viral infection.
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activity, i.e., the capacity to cleave DEVD-pNA, a synthetic
analog of the natural substrates of caspase-3 and -7. As shown
in Fig. 8A, infection with the C19A/C22A mutant resulted in a
marked and early (i.e., already at 5 h p.i.) activation of a
DEVDase. This activity was only slightly increased by 7 h p.i.,
and it was practically fully inhibited by QVD. The cells infected
with wt MV also demonstrated an increase in DEVDase ac-
tivity, which, at 5 h p.i., was significantly lower than that of the
mutant-infected cells, and approached a similarly high level
during the next 2 h. A comparable increase in DEVDase ac-
tivity also was observed in cells infected with EMCV (not
shown). The ability of wt virus to activate DEVDase activity
was unexpected, because no obvious signs of apoptosis were
observed under such conditions.
To identify the caspase(s) activated upon infection, immu-
noblot assays were performed. The results (Fig. 8B) demon-
strated the proteolytic cleavage (suggestive of activation) of
caspase-9 and -3 and, to a lesser extent, of caspase-8 in the
L-deficient mutant-infected cells already at 5 h p.i., with more
intense bands of proteolytic products at 7 h p.i. Some activa-
tion, albeit less prominent and occurring later (i.e., at 7 h p.i.),
was observed in wt-infected cells, in line with the results of the
DEVDase assay. Similar proteolytic products also were de-
tected in cells undergoing CHI-elicited apoptosis. QVD pre-
vented the processing of procaspases (in the case of caspase-3,
an aberrant proteolytic product was reproducibly observed in
samples treated with the inhibitor).
To further characterize the pathway leading to apoptosis in
cells infected with the L mutant, we looked at the status of
mitochondria and cytochrome c. To this end, cells expressing
the enhanced yellow fluorescent protein fused with the mito-
chondria-targeting sequence from human cytochrome c oxi-
dase (EYFP-mito) were generated. An advantage of these cells
consisted in the possibility to evaluate mitochondrial fragmen-
tation independently of cytochrome efflux. The former could
be judged by the altered pattern of fluorescence emitted by
EYFP (transition from thread-like to punctated signals),
whereas the latter could be seen as diffuse clouds after immu-
nostaining with anti-cytochrome antibodies. In cells infected
with the C19A/C22A mutant, mitochondria were fragmented
and the extensive exit of cytochrome c from mitochondria
could be demonstrated by 7 h p.i. (Fig. 9A). The proportion of
the mutant-infected cells exhibiting cytochrome c efflux was
significantly greater than that in cells rendered apoptotic after
FIG. 3. EMCV inhibition of ActD-triggered apoptosis. (A) HeLa cells were preincubated in serum-free medium for 1.5 h and then mock
infected or EMCV infected and incubated at 37°C for 5 h in the absence and presence of 3 g/ml ActD. The cells were stained for the TUNEL
assay and with Hoechst-33342. (B) Quantification of TUNEL-positive cells in the cell populations from the experiment shown in panel A.
(C) Electrophoretic investigation of DNA from cell samples shown in panel A. (D) Samples similar to those shown in panel A were immunostained
for cytochrome c.
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treatment with CHI (Fig. 9B). On the other hand, nearly no wt
virus-infected cells demonstrated the exit of cytochrome c from
fragmented mitochondria (in line with data in Fig. 2). The
anti-caspase drug QVD failed to prevent mitochondrion fission
in cells infected with wt and L-deficient MV, indicating that
this fission took place upstream of caspase activation; the cy-
toplasmic exit of cytochrome c in mutant-infected cells also
was not prevented (Fig. 9).
Thus, infection with the L-deficient cardiovirus activated a
caspase-dependent, cytochrome c-mediated apoptotic path-
way. This activation appeared to be due, at least in part, to
alterations in the mitochondrial structure, and in particular to
the enhanced permeability of its outer membrane, allowing
cytochrome c efflux. The mitochondrial injury occurred
through a caspase-independent mechanism, since neither frag-
mentation nor cytochrome c efflux triggered by the mutant
were prevented by the caspase inhibitor.
DISCUSSION
Apoptosis-triggering and apoptosis-preventing functions of
cardioviruses. The results presented here demonstrate that
EMCV is capable of switching on two opposing pathways in
HeLa cells, the host defensive apoptotic response and a viral
antiapoptotic counterdefense. As a result of the dominance of
the latter, the cells died without obvious signs of apoptosis. In
possessing both apoptosis-triggering and apoptosis-suppress-
ing activities, cardioviruses resemble poliovirus (3, 8, 9, 13, 95)
and coxsackievirus B3 (22, 36, 85). It is yet to be determined
whether other representatives of the picornavirus family also
are equipped with these opposing functions.
The competition between the opposing programs may in-
volve multiple players and is influenced by a variety of genetic
(viral and cellular), physiological, and environmental factors.
The contribution of host factors is illustrated by the ability of
cardioviruses to induce apoptosis in some, but not all, types of
cells (5, 50, 51, 87, 103). Furthermore, the L-deficient MV,
exhibiting a highly apoptogenic activity in HeLa cells, failed to
elicit apoptosis in a subline of BHK-21 cells, which proved to
be resistant to certain nonviral apoptotic inducers as well (un-
published data). For poliovirus, variable responses of apoptotic
machinery of different cells also were reported: this virus, being
unable to induce apoptosis in productively infected HeLa cells
(2, 95), triggered apoptosis in others (4, 9, 84). On the other
hand, abortive poliovirus infection fails to trigger apoptosis in
RD cells (84).
One of the possible reasons for the variation of the out-
comes of cardiovirus-cell interactions could be the rate of the
accumulation of L in the infected cells as well as the biological
relevance of cellular targets of L in specific cells. The time
course and efficiency of different steps of viral reproduction in
these cells also may affect this outcome. The consequences of
FIG. 4. MV (mengo) inhibition of apoptosis triggered by restrictive
poliovirus infection. HeLa cells were infected with poliovirus (MOI,
800 PFU/cell), and simultaneously portions of samples (the right
column) were infected with wt MV (MOI, 10 PFU/cell). Guanidine-
HCl (100 g/ml) was added at 1.5 h p.i. to all cultures (poliovirus 
gua). The cells were fixed at 7 h p.i. and stained for the TUNEL assay
and with Hoechst-33342. The yield of MV was not appreciably changed
in the presence of guanidine.
FIG. 5. Effects of mutations in the L protein on MV reproduction in HeLa cells. Accumulation of infectious virus (A) and viral RNA molecules
(B) during the one-step growth of wt and C19A/C22A MVs, as determined by plaques assay and real-time PCR, respectively. The input MOI for
both viruses was 20 PFU/cell. Average data  standard deviations for seven independent experiments are shown in panel A, and those for two
(at 3 h p.i.) and three (at 5 and 7 h p.i.) independent experiments are shown in panel B. At least three replicate cultures were investigated at each
time point in each real-time experiment.
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the trade-off between viral apoptosis-inducing and apoptosis-
preventing activities are not expected to be uniform either. In
certain picornavirus/cell systems, the inhibition of apoptosis
may adversely affect viral reproduction and/or externalization
(32, 65). In contrast, the yield of infectious L-deficient MV in
HeLa cells was essentially unaffected by QVD, a caspase in-
hibitor.
Accordingly, one should be cautious in extrapolating obser-
vations made in one type of cells to another one, and especially
to the events occurring in the infected organism. TMEV (86,
96, 97), porcine EMCV (17), and poliovirus (39) were reported
to elicit apoptosis in certain cells of animals. It is not clear if
these apoptotic events always developed as a direct conse-
quence of viral reproduction in the target cells or if they were
due to some secondary, e.g., immunological, reaction (52). If
the former explanation is true, it means that the viral antiapop-
totic function was not efficient enough to overcome the apop-
totic responses in these cases. However, this should not nec-
essarily be so in some other in vivo settings.
The apoptotic program elicited by cardioviruses. The acti-
vation of the apoptotic program upon cardiovirus infection
becomes evident when the viral antiapoptotic function(s) is
suppressed, as is the case in infection with L-deficient mutants
(another MV mutant with a nearly complete deletion of L
protein exhibited apoptosis-inducing activity similar to that of
the Zn finger mutant described above; unpublished data). Un-
der these conditions, numerous hallmarks of apoptosis were
observed: cytochrome c exit from mitochondria, the activation
of caspase-9, caspase-3, and caspase-8, cytoplasmic blebbing,
chromatin condensation, nuclear fragmentation, and extensive
FIG. 6. Apoptosis-triggering activity of L-deficient MV mutant. (A) HeLa cells were mock infected or infected (MOI, 20 PFU/ml) with wt
MV or its L mutant for 7 h at 37°C, and then they were stained with Hoechst-33342 and for the TUNEL assay. Appropriate samples were
incubated with 20 M QVD. The virus yields in the absence and presence of the inhibitor were essentially the same, 257 and 285 PFU/cell,
respectively. (B) Quantification of TUNEL-positive cells in samples of cells in the experiment shown in panel A. (C) Electrophoretic investigation
of DNA from mock-infected and virus-infected cells.
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DNA degradation (as revealed by both TUNEL assay
and electrophoretic analysis). Collectively, these alterations
pointed to the involvement of a mitochondrion-dependent,
cytochrome c-dependent, and caspase-dependent apoptotic
pathway(s).
Picornaviruses are known to activate apoptotic pathways
through interaction with plasma membrane receptors or intra-
cellular sensors (8, 15, 53, 102). Viral capsid proteins were
implicated in triggering apoptosis both from without (9, 53, 76)
and from within the cell (47, 62). Other possible players are
viral proteases 3C and 2A (18, 26, 42, 60, 105) and viral non-
structural proteins 2B, 3A (64), and 2C (63). Double-stranded
RNA also may serve as an apoptosis inducer (49, 99). How-
ever, the exact nature of cardioviral activator(s) of the apop-
totic pathway(s) and of their immediate cellular targets have
yet to be elucidated.
An intriguing observation made in this study was mitochon-
drial fragmentation in the virus-infected cells. In other systems,
mitochondrial fission may take place either upstream or down-
stream of the mitochondrial membrane permeabilization, a
key step in the mitochondrion-dependent apoptotic pathways
(24, 77, 104). A possibility that this fission is an upstream event
in the cardiovirus-activated apoptotic pathway is in line with
the recently reported ability of poliovirus 2B and 3A proteins
to induce the fragmentation of the organelle (64). However,
further research is needed to ascertain the significance of mi-
tochondrial fission for cardiovirus-triggered apoptosis.
The antiapoptotic program elicited by cardioviruses. The
nature of the cardiovirus antiapoptotic program is even less
certain. Only limited information is available on the antiapop-
totic tools exploited by other picornaviruses. Coxsackievirus B3
(36) and poliovirus (8) were reported to activate the phospha-
tidylinositol 3-kinase/Akt signaling pathway, thereby promot-
ing cell survival. 2B protein of the former virus may suppress
the apoptotic program by changing intracellular distribution of
Ca2 (21). Other antiapoptotic mechanisms used by enterovi-
ruses may involve the inactivation or degradation of caspases
(13, 85) and the depletion of receptors of extracellular pro-
FIG. 7. Effect of the interruption of EMCV and poliovirus (polio)
reproduction on the development of apoptotic response. HeLa cells
were infected with EMCV or poliovirus (both at an MOI of 500
PFU/cell), and CHI (final concentration, 10 g/ml) was added to
appropriate samples at 1.5 h p.i. Cells were fixed at 7 h p.i., and the
proportion of TUNEL-positive cells was determined.
FIG. 8. Effects of infection with wt and C19A/C22A mutant MVs on caspase activation. (A) DEVDase activation. HeLa cells were infected with
appropriate viruses for 7 h, and DEVDase activity was assayed in cell extracts prepared at 5 and 7 h p.i. as described in Materials and Methods.
(B) Western blot analysis of partial proteolysis of caspase-3, -8, and -9 in virus-infected cells at 5 and 7 h p.i. and in cells treated with 100 g/ml
of CHI for 5 h. The bands corresponding to procaspase-9 and processed caspases are marked by arrowhead and arrows, respectively. A
slower-migrating band in the caspase-3 assay in the presence of QVD (asterisk) was reproducible in the inhibitor-containing samples; its nature
was not further investigated.
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apoptotic ligands (72). In other viruses, a much greater variety
of viral antiapoptotic tools are known (6, 20, 28, 68, 73, 74, 93,
94, 101). These tools may operate at transcriptional or posttran-
scriptional levels, with targets in mitochondria as well as upstream
or downstream of them. The antiapoptotic state elicited by car-
dioviruses may exploit some of these mechanisms.
This study implicates cardiovirus L protein in the viral anti-
apoptotic activity; indeed, its inactivation led to the develop-
ment of apoptosis. The mechanism of this antiapoptotic func-
tion has yet to be determined. It cannot be ruled out that it is
associated, at least in part, with the less efficient growth of L
mutants. Indeed, the balance of viral apoptosis-triggering and
apoptosis-suppressing functions, whatever their nature, could
well depend on the time course of the synthesis of relevant
proteins. This may explain the apoptotic activity of wt cardio-
viruses under partially restrictive conditions in certain systems
(50, 51). However, the somewhat impaired reproduction of
L-deficient mutants is hardly a decisive cause of their apoptotic
activity. The difference between the infectious particles (or
RNA molecules) of wt and L virus produced by 5 h p.i. (when
there already was a marked apoptosis in the mutant-infected
cells; not shown) was relatively small. Moreover, the interrup-
tion of cardiovirus reproduction by a low dose of CHI did not
lead to apoptosis. We propose that L protein has a more direct
target(s) among the components of the cellular apoptotic/
antiapoptotic machinery.
As mentioned above, we detected the fragmentation of mi-
tochondria upon infection with wt virus, when the development
of apoptosis essentially was suppressed. This fission was not
accompanied with the exit of cytochrome c into the cytoplasm.
Therefore, one may speculate that the wt EMCV-elicited mi-
tochondrial fission is involved in the viral antiapoptotic func-
tion rather than representing an upstream apoptotic event.
Indeed, it was reported that mitochondrial fission may sup-
press apoptosis in some cases, e.g., upon ceramide treatment,
oxidative stress, or serum deprivation (77, 91). Under these
conditions, a major proapoptotic factor is the redistribution of
Ca2 from endoplasmic reticulum stores to mitochondria. The
fragmentation of these organelles would result in impeding the
propagation of Ca2 waves through the mitochondrial network
FIG. 9. Fragmentation of mitochondria and cytoplasmic exit of cytochrome c in cells infected with the L mutant. (A) HeLa cells expressing
mitochondria-targeted EYFP (EYFP-mito) were infected with wt and C19A/C22A MVs for 7 h or were treated with 100 g/ml of CHI for 4 h and
investigated for the localization of cytochrome c by indirect immunofluorescence or mitochondrial integrity by the direct observation of EYFP.
Appropriate samples were incubated in the presence of 20 M QVD during infection or CHI treatment. DNA was stained with Hoechst 33342.
(B) Percentage of cells demonstrating cytochrome c efflux.
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(77, 91). If mitochondrial fission plays a role in the cardiovirus
antiapoptotic activity, one may further speculate that an alter-
ation in Ca2 distribution is an important component of the
apoptotic response to EMCV infection. It is noteworthy that
the expression of EMCV protein 2B leads to a decrease in
Ca2 content within the endoplasmic reticulum (29).
Interestingly, a viral protein is known that exert its antiapop-
totic function via mitochondrial fission. The immediate-early
protein vMIA of human cytomegalovirus (41) recruits pro-
apoptotic protein Bax to mitochondria and somehow inacti-
vates it there (7, 79); this process is associated with the disrup-
tion of the mitochondrial network (67). The antiapoptotic state
elicited by vMIA is effective against nonviral apoptosis induc-
ers (66). However, we were unable to reveal any significant
similarity between amino acid sequences of vMIA and cardio-
virus L.
Another intriguing observation was the activation of several
caspases in nonapoptotic HeLa cells infected with wt cardio-
viruses. The activation of caspase-8, -9, -3, and -7 late upon
EMCV infection (at 7 and 24 h p.i.) also was reported by
others (49). A broad group of viral antiapoptotic proteins are
known to counteract various caspase activators or caspases
themselves (20, 85). However, the interruption of an apoptotic
pathway downstream of caspase activation is rather puzzling. It
suggests the existence of another cardiovirus antiapoptotic
function, operating downstream of caspases and suppressing
significant DNA degradation. Further research is needed to
clarify this point.
Cardiovirus L exhibits a variety of effects on the innate
immunity system (see below). It has yet to be elucidated how
and whether these diverse effects are related to each other.
It should be noted that the genome of some, but not all,
strains of TMEV contains, within the L-coding gene, an out-
of-frame sequence encoding a short polypeptide, called L*
(58), which was reported to exhibit antiapoptotic activity (38,
48). However, EMCV does not express L*, and EMCV L has
no structural resemblance to L* of TMEV-like viruses.
Cardiovirus L protein as a security protein. The leader
proteins of cardioviruses are not essential for viral reproduc-
tion, as evidenced by the viability of L-deleted mutants in
certain cells (19, 57, 106). These proteins appeared to target
predominantly host metabolism and infrastructure by inhibit-
ing host translation (35, 106), interfering with the interferon
system (46, 83, 98, 107), increasing the bidirectional perme-
ability of the nuclear pores and inhibiting active nucleocyto-
plasmic transport (11, 30, 61, 80, 81), and suppressing apopto-
sis (this study). We suggest that such nonessential anti-host
proteins could be named security proteins.
Bearing the same name but being structurally unrelated, the
L protein of aphthoviruses, a protease, also is not essential
(78), but it inhibits host translation by the cleavage of transla-
tion initiation factors and disables the host interferon system
(31, 33, 45). Remarkably, 2A protein of cardioviruses, being
nonessential though important (69, 90, 108), also exhibits anti-
host functions by inhibiting cell translation (44). 2A protease
proteins of enterovirus and rhinovirus (unrelated to 2A pro-
teins of cardioviruses), though apparently essential (70), also
perform a set of anti-defensive functions very similar to those
exhibited by L proteins of cardioviruses and aphthoviruses,
namely the inhibition of host translation (59), the disruption of
controllable nucleocytoplasmic traffic (12, 75), the suppression
of interferon action (71), and others (56). We propose that L
proteins of aphthoviruses as well as 2A proteins of cardiovi-
ruses, enteroviruses, and rhinoviruses also be included in the
group of security proteins. It seems likely that this group will be
joined by other picornavirus proteins.
The fact that the picornavirus security proteins, despite their
structural unrelatedness, serve similar functions (largely or
even solely neutralizing host antidefenses) strongly suggests
that they had been acquired independently, and perhaps rela-
tively recently, in the course of evolution, and that the major
driving force behind these acquisitions was positive selection
for anti-defensive capabilities.
Obviously, the possession of security proteins is not an ex-
clusive privilege of picornaviruses.
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ADDENDUM IN PROOF
After the article was revised, we became aware of a paper by
Fan et al. (J. Fan, K.-N. Son, S. Y. Arslan, Z. Liang, and H. L.
Lipton, J. Virol., 83:6546–6553, 2009) reporting that ectopic
expression of individual Theiler’s murine encephalomyelitis
virus (BeAn strain) leader protein in BHK-21 cells resulted in
the development of apoptosis. It therefore seems that cardio-
virus L proteins may, depending on conditions, exihibit either
antiapoptotic or proapoptoic activity.
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